1. Report Introduction
2. Chronic Thromboembolic Pulmonary Hypertension Epidemiology Overview at a Glance
3. Market Share Distribution of Chronic Thromboembolic Pulmonary Hypertension
4. Disease Background and Overview: Chronic Thromboembolic Pulmonary Hypertension
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Chronic Thromboembolic Pulmonary Hypertension Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Chronic Thromboembolic Pulmonary Hypertension by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
7.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
7.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
7.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
7.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
8.1.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
8.1.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
8.1.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
8.1.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
8.2.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
8.2.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
8.2.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
8.2.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
8.3.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
8.3.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
8.3.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
8.3.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
8.4.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
8.4.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
8.4.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
8.4.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
8.5.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
8.5.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
8.5.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
8.5.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Chronic Thromboembolic Pulmonary Hypertension
9.3. Sub-Type Specific cases of Chronic Thromboembolic Pulmonary Hypertension*
9.4. Sex- Specific Cases of Chronic Thromboembolic Pulmonary Hypertension*
9.5. Diagnosed Cases of Chronic Thromboembolic Pulmonary Hypertension
9.6. Treated Cases of Chronic Thromboembolic Pulmonary Hypertension
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.